img

Global Hepatitis A and B Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hepatitis A and B Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The hepatitis A and hepatitis B vaccines can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
Hepatitis A and B Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hepatitis A and B Vaccine market is projected to reach US$ 2037.4 million in 2029, increasing from US$ 1798.9 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2029. Demand from Government Institution and Private Sector are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatitis A and B Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Segment by Type
Hepatitis A Vaccination
Hepatitis B Vaccination

Segment by Application


Government Institution
Private Sector
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hepatitis A and B Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hepatitis A and B Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hepatitis A and B Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hepatitis A and B Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hepatitis A and B Vaccine introduction, etc. Hepatitis A and B Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hepatitis A and B Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hepatitis A and B Vaccine Market Overview
1.1 Hepatitis A and B Vaccine Product Overview
1.2 Hepatitis A and B Vaccine Market Segment by Type
1.2.1 Hepatitis A Vaccination
1.2.2 Hepatitis B Vaccination
1.3 Global Hepatitis A and B Vaccine Market Size by Type
1.3.1 Global Hepatitis A and B Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Hepatitis A and B Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hepatitis A and B Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hepatitis A and B Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hepatitis A and B Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hepatitis A and B Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hepatitis A and B Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hepatitis A and B Vaccine Sales Breakdown by Type (2018-2024)
2 Global Hepatitis A and B Vaccine Market Competition by Company
2.1 Global Top Players by Hepatitis A and B Vaccine Sales (2018-2024)
2.2 Global Top Players by Hepatitis A and B Vaccine Revenue (2018-2024)
2.3 Global Top Players by Hepatitis A and B Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Hepatitis A and B Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hepatitis A and B Vaccine Market Competitive Situation and Trends
2.5.1 Hepatitis A and B Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hepatitis A and B Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Hepatitis A and B Vaccine Market
2.8 Key Manufacturers Hepatitis A and B Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hepatitis A and B Vaccine Status and Outlook by Region
3.1 Global Hepatitis A and B Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hepatitis A and B Vaccine Historic Market Size by Region
3.2.1 Global Hepatitis A and B Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Hepatitis A and B Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Hepatitis A and B Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hepatitis A and B Vaccine Forecasted Market Size by Region
3.3.1 Global Hepatitis A and B Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Hepatitis A and B Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Hepatitis A and B Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hepatitis A and B Vaccine by Application
4.1 Hepatitis A and B Vaccine Market Segment by Application
4.1.1 Government Institution
4.1.2 Private Sector
4.1.3 Other
4.2 Global Hepatitis A and B Vaccine Market Size by Application
4.2.1 Global Hepatitis A and B Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Hepatitis A and B Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hepatitis A and B Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hepatitis A and B Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hepatitis A and B Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hepatitis A and B Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hepatitis A and B Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hepatitis A and B Vaccine Sales Breakdown by Application (2018-2024)
5 North America Hepatitis A and B Vaccine by Country
5.1 North America Hepatitis A and B Vaccine Historic Market Size by Country
5.1.1 North America Hepatitis A and B Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hepatitis A and B Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Hepatitis A and B Vaccine Sales in Value by Country (2018-2024)
5.2 North America Hepatitis A and B Vaccine Forecasted Market Size by Country
5.2.1 North America Hepatitis A and B Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Hepatitis A and B Vaccine Sales in Value by Country (2024-2029)
6 Europe Hepatitis A and B Vaccine by Country
6.1 Europe Hepatitis A and B Vaccine Historic Market Size by Country
6.1.1 Europe Hepatitis A and B Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hepatitis A and B Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Hepatitis A and B Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Hepatitis A and B Vaccine Forecasted Market Size by Country
6.2.1 Europe Hepatitis A and B Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Hepatitis A and B Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Hepatitis A and B Vaccine by Region
7.1 Asia-Pacific Hepatitis A and B Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Hepatitis A and B Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hepatitis A and B Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hepatitis A and B Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hepatitis A and B Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Hepatitis A and B Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hepatitis A and B Vaccine Sales in Value by Region (2024-2029)
8 Latin America Hepatitis A and B Vaccine by Country
8.1 Latin America Hepatitis A and B Vaccine Historic Market Size by Country
8.1.1 Latin America Hepatitis A and B Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hepatitis A and B Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hepatitis A and B Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Hepatitis A and B Vaccine Forecasted Market Size by Country
8.2.1 Latin America Hepatitis A and B Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hepatitis A and B Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Hepatitis A and B Vaccine by Country
9.1 Middle East and Africa Hepatitis A and B Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Hepatitis A and B Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hepatitis A and B Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hepatitis A and B Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hepatitis A and B Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Hepatitis A and B Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hepatitis A and B Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Hepatitis A and B Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Hepatitis A and B Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Hepatitis A and B Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Sinovac
10.4.1 Sinovac Company Information
10.4.2 Sinovac Introduction and Business Overview
10.4.3 Sinovac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sinovac Hepatitis A and B Vaccine Products Offered
10.4.5 Sinovac Recent Development
10.5 Zhejiang Pukang
10.5.1 Zhejiang Pukang Company Information
10.5.2 Zhejiang Pukang Introduction and Business Overview
10.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Products Offered
10.5.5 Zhejiang Pukang Recent Development
10.6 Changchun Institute of Biological
10.6.1 Changchun Institute of Biological Company Information
10.6.2 Changchun Institute of Biological Introduction and Business Overview
10.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Products Offered
10.6.5 Changchun Institute of Biological Recent Development
10.7 KM Biologics
10.7.1 KM Biologics Company Information
10.7.2 KM Biologics Introduction and Business Overview
10.7.3 KM Biologics Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 KM Biologics Hepatitis A and B Vaccine Products Offered
10.7.5 KM Biologics Recent Development
10.8 IMBCAMS
10.8.1 IMBCAMS Company Information
10.8.2 IMBCAMS Introduction and Business Overview
10.8.3 IMBCAMS Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 IMBCAMS Hepatitis A and B Vaccine Products Offered
10.8.5 IMBCAMS Recent Development
10.9 Convac
10.9.1 Convac Company Information
10.9.2 Convac Introduction and Business Overview
10.9.3 Convac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Convac Hepatitis A and B Vaccine Products Offered
10.9.5 Convac Recent Development
10.10 NCPC
10.10.1 NCPC Company Information
10.10.2 NCPC Introduction and Business Overview
10.10.3 NCPC Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 NCPC Hepatitis A and B Vaccine Products Offered
10.10.5 NCPC Recent Development
10.11 Bio Kangtai
10.11.1 Bio Kangtai Company Information
10.11.2 Bio Kangtai Introduction and Business Overview
10.11.3 Bio Kangtai Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bio Kangtai Hepatitis A and B Vaccine Products Offered
10.11.5 Bio Kangtai Recent Development
10.12 Dynavax
10.12.1 Dynavax Company Information
10.12.2 Dynavax Introduction and Business Overview
10.12.3 Dynavax Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Dynavax Hepatitis A and B Vaccine Products Offered
10.12.5 Dynavax Recent Development
10.13 Hissen
10.13.1 Hissen Company Information
10.13.2 Hissen Introduction and Business Overview
10.13.3 Hissen Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hissen Hepatitis A and B Vaccine Products Offered
10.13.5 Hissen Recent Development
10.14 LG Life Sciences
10.14.1 LG Life Sciences Company Information
10.14.2 LG Life Sciences Introduction and Business Overview
10.14.3 LG Life Sciences Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 LG Life Sciences Hepatitis A and B Vaccine Products Offered
10.14.5 LG Life Sciences Recent Development
10.15 Serum Institute
10.15.1 Serum Institute Company Information
10.15.2 Serum Institute Introduction and Business Overview
10.15.3 Serum Institute Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Serum Institute Hepatitis A and B Vaccine Products Offered
10.15.5 Serum Institute Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hepatitis A and B Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hepatitis A and B Vaccine Industrial Chain Analysis
11.4 Hepatitis A and B Vaccine Market Dynamics
11.4.1 Hepatitis A and B Vaccine Industry Trends
11.4.2 Hepatitis A and B Vaccine Market Drivers
11.4.3 Hepatitis A and B Vaccine Market Challenges
11.4.4 Hepatitis A and B Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hepatitis A and B Vaccine Distributors
12.3 Hepatitis A and B Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hepatitis A Vaccination
Table 2. Major Company of Hepatitis B Vaccination
Table 3. Global Hepatitis A and B Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Hepatitis A and B Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Hepatitis A and B Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Hepatitis A and B Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Hepatitis A and B Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Hepatitis A and B Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Hepatitis A and B Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Hepatitis A and B Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Hepatitis A and B Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Hepatitis A and B Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Hepatitis A and B Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Hepatitis A and B Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Hepatitis A and B Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Hepatitis A and B Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Hepatitis A and B Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Hepatitis A and B Vaccine Sales Share by Company (2018-2024)
Table 26. Global Hepatitis A and B Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Hepatitis A and B Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Hepatitis A and B Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Hepatitis A and B Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Hepatitis A and B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Hepatitis A and B Vaccine Market
Table 33. Key Manufacturers Hepatitis A and B Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hepatitis A and B Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Hepatitis A and B Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Hepatitis A and B Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Hepatitis A and B Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Hepatitis A and B Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Hepatitis A and B Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Hepatitis A and B Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Hepatitis A and B Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Hepatitis A and B Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Hepatitis A and B Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Hepatitis A and B Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Hepatitis A and B Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Hepatitis A and B Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Hepatitis A and B Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Hepatitis A and B Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Hepatitis A and B Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Hepatitis A and B Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Hepatitis A and B Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Hepatitis A and B Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Hepatitis A and B Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Hepatitis A and B Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Hepatitis A and B Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Hepatitis A and B Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Hepatitis A and B Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Hepatitis A and B Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Hepatitis A and B Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Hepatitis A and B Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Hepatitis A and B Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Hepatitis A and B Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Hepatitis A and B Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. GSK Company Information
Table 108. GSK Introduction and Business Overview
Table 109. GSK Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. GSK Hepatitis A and B Vaccine Product
Table 111. GSK Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Hepatitis A and B Vaccine Product
Table 116. Merck Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Hepatitis A and B Vaccine Product
Table 121. Sanofi Recent Development
Table 122. Sinovac Company Information
Table 123. Sinovac Introduction and Business Overview
Table 124. Sinovac Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sinovac Hepatitis A and B Vaccine Product
Table 126. Sinovac Recent Development
Table 127. Zhejiang Pukang Company Information
Table 128. Zhejiang Pukang Introduction and Business Overview
Table 129. Zhejiang Pukang Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Zhejiang Pukang Hepatitis A and B Vaccine Product
Table 131. Zhejiang Pukang Recent Development
Table 132. Changchun Institute of Biological Company Information
Table 133. Changchun Institute of Biological Introduction and Business Overview
Table 134. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Changchun Institute of Biological Hepatitis A and B Vaccine Product
Table 136. Changchun Institute of Biological Recent Development
Table 137. KM Biologics Company Information
Table 138. KM Biologics Introduction and Business Overview
Table 139. KM Biologics Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. KM Biologics Hepatitis A and B Vaccine Product
Table 141. KM Biologics Recent Development
Table 142. IMBCAMS Company Information
Table 143. IMBCAMS Introduction and Business Overview
Table 144. IMBCAMS Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. IMBCAMS Hepatitis A and B Vaccine Product
Table 146. IMBCAMS Recent Development
Table 147. Convac Company Information
Table 148. Convac Introduction and Business Overview
Table 149. Convac Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Convac Hepatitis A and B Vaccine Product
Table 151. Convac Recent Development
Table 152. NCPC Company Information
Table 153. NCPC Introduction and Business Overview
Table 154. NCPC Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. NCPC Hepatitis A and B Vaccine Product
Table 156. NCPC Recent Development
Table 157. Bio Kangtai Company Information
Table 158. Bio Kangtai Introduction and Business Overview
Table 159. Bio Kangtai Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Bio Kangtai Hepatitis A and B Vaccine Product
Table 161. Bio Kangtai Recent Development
Table 162. Dynavax Company Information
Table 163. Dynavax Introduction and Business Overview
Table 164. Dynavax Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Dynavax Hepatitis A and B Vaccine Product
Table 166. Dynavax Recent Development
Table 167. Hissen Company Information
Table 168. Hissen Introduction and Business Overview
Table 169. Hissen Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Hissen Hepatitis A and B Vaccine Product
Table 171. Hissen Recent Development
Table 172. LG Life Sciences Company Information
Table 173. LG Life Sciences Introduction and Business Overview
Table 174. LG Life Sciences Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. LG Life Sciences Hepatitis A and B Vaccine Product
Table 176. LG Life Sciences Recent Development
Table 177. Serum Institute Company Information
Table 178. Serum Institute Introduction and Business Overview
Table 179. Serum Institute Hepatitis A and B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Serum Institute Hepatitis A and B Vaccine Product
Table 181. Serum Institute Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Hepatitis A and B Vaccine Market Trends
Table 185. Hepatitis A and B Vaccine Market Drivers
Table 186. Hepatitis A and B Vaccine Market Challenges
Table 187. Hepatitis A and B Vaccine Market Restraints
Table 188. Hepatitis A and B Vaccine Distributors List
Table 189. Hepatitis A and B Vaccine Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A and B Vaccine Product Picture
Figure 2. Global Hepatitis A and B Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hepatitis A and B Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Hepatitis A and B Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Hepatitis A Vaccination
Figure 6. Global Hepatitis A Vaccination Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Hepatitis B Vaccination
Figure 8. Global Hepatitis B Vaccination Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Hepatitis A and B Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Hepatitis A and B Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Hepatitis A and B Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Hepatitis A and B Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Hepatitis A and B Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Hepatitis A and B Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Hepatitis A and B Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Hepatitis A and B Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatitis A and B Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatitis A and B Vaccine Revenue in 2022
Figure 23. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Government Institution
Figure 25. Global Government Institution Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Private Sector
Figure 27. Global Private Sector Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Hepatitis A and B Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Hepatitis A and B Vaccine Sales Market Share by Application in 2022 & 2029
Figure 32. North America Hepatitis A and B Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Hepatitis A and B Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Hepatitis A and B Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Hepatitis A and B Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Hepatitis A and B Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Hepatitis A and B Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Hepatitis A and B Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Hepatitis A and B Vaccine Manufacturing Cost Structure
Figure 43. Hepatitis A and B Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed